Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Bills/119th Congress · House

H.R. 8901

Introduced

Securing Innovation and Research from Adversaries Act

Sponsor
RJohn R. Moolenaar· Michigan
Introduced
May 19, 2026
Policy area
Science, Technology, Communications
Latest action
Referred to the House Committee on Science, Space, and Technology.May 19, 2026
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 8901 Introduced in House (IH)]

<DOC>

119th CONGRESS
2d Session
H. R. 8901

To prohibit certain federally funded research collaborations with 
certain foreign entities, and for other purposes.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

May 19, 2026

Mr. Moolenaar introduced the following bill; which was referred to the 
Committee on Science, Space, and Technology

_______________________________________________________________________

A BILL

To prohibit certain federally funded research collaborations with 
certain foreign entities, and for other purposes.

Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the ``Securing Innovation and Research 
from Adversaries Act''.

SEC. 2. PROHIBITION ON FEDERALLY FUNDED RESEARCH RELATIONSHIPS WITH 
CERTAIN FOREIGN ENTITIES.

(a) Prohibition.--No Federal funds awarded through a grant, 
contract, cooperative agreement, or any other form of Federal financial 
assistance or other awards issued under other transaction authority (in 
this section referred to as a ``federally funded research award'') may 
be used by an individual or entity described in subsection (b) to enter 
into, support, or carry out any research collaboration with either--
(1) an entity listed on a United States Government 
restricted entity list; or
(2) an individual associated with such an entity.
(b) Individual or Entity.--An individual or entity described in 
this subsection is an individual or entity participating in, receiving, 
or performing work under a federally funded research award.
(c) Guidance.--To carry out this section, the Director of the 
Office of Science and Technology Policy, in consultation with the heads 
of relevant Federal research agencies, shall issue government-wide 
implementation guidance to ensure standardized compliance requirements, 
definitions, and enforcement mechanisms.
(d) Waiver Authority.--
(1) In general.--The head of a Federal agency may waive the 
prohibition under subsection (a), on a case-by-case basis, if 
such head determines--
(A) such waiver is necessary to advance the 
national security interests of the United States; or
(B) the research collaboration under subsection (a) 
that is the subject of such waiver is essential for a 
clearly defined scientific, public health, or national 
security purpose that cannot reasonably be achieved 
without such collaboration.
(2) Report.--Not later than 30 days after granting a waiver 
under paragraph (1), the head of the Federal agency who so 
granted such waiver shall submit to Congress a written 
notification that includes the following:
(A) The identity of the individual or entity that 
is the subject of such waiver.
(B) The justification for such waiver.
(C) The mitigation measures implemented to protect 
the national security interests of the United States, 
if applicable.
(e) Definitions.--In this section:
(1) Research collaboration.--The term ``research 
collaboration'' means any activity conducted as part of a 
federally funded research award, including the following:
(A) Joint research activities or projects.
(B) Co-authorship of scholarly publications, 
technical reports, or research outputs.
(C) Data sharing or processing, material transfer, 
or exchange of research results, including access to 
datasets, software, or research infrastructure.
(D) Joint laboratories, research centers, or 
institutes.
(E) Personnel exchanges, visiting scholar 
appointments, or joint supervision of students or 
researchers.
(F) Any other arrangement determined by the head of 
the relevant Federal research funding agency to 
constitute research collaboration.
(2) National laboratory.--The term ``National Laboratory'' 
has the meaning given such term in section 2 of the Energy 
Policy Act of 2005 (42 U.S.C. 15801).
(3) United states government restricted entity lists.--The 
term ``United States Government restricted entity list'' 
includes the following:
(A) The Department of Commerce Bureau of Industry 
and Security Entity List (Supplement No. 4 to Part 744 
of the Export Administration Regulations).
(B) The Department of Commerce Bureau of Industry 
and Security Military End User List.
(C) The Department of the Treasury Office of 
Foreign Assets Control Specially Designated Nationals 
List.
(D) The Denied Persons List maintained by the 
Bureau of Industry and Security of the Department of 
Commerce and described in section 764.3(a)(2) of the 
Export Administration Regulations.
(E) The Department of Defense Chinese Military 
Companies List maintained pursuant to section 1260H of 
the National Defense Authorization Act for Fiscal Year 
2021 (10 U.S.C. 113 note).
(F) The Debarred Parties List maintained by the 
Directorate of Defense Trade Controls of the Department 
of State.
(G) The list of telecommunications companies of the 
People's Republic of China designated under section 889 
of the John S. McCain National Defense Authorization 
Act for Fiscal Year 2019 (Public Law 115-232) as posing 
national security risks to the United States.
(H) The list of institutions of higher education 
and other entities determined to be affiliated with, or 
supporting, the People's Republic of China's military-
civil fusion strategy maintained pursuant to section 
1286 of the John S. McCain National Defense 
Authorization Act for Fiscal Year 2019 (10 U.S.C. 2358 
note).
(I) The list of semiconductor companies of the 
People's Republic of China and affiliates designated 
under section 5949 of the James M. Inhofe National 
Defense Authorization Act for Fiscal Year 2023 (Public 
Law 117-263; 41 U.S.C. 4713 note) as posing national 
security risks to the United States.
(J) The Annex to Executive Order (EO) 14032, 
``Addressing the Threat from Securities Investments 
That Finance Certain Companies of the People's Republic 
of China,'' dated June 3, 2021, or superseding 
Executive order.
(K) The list maintained by the Federal 
Communications Commission of equipment and services 
covered by section 2 of the Secure and Trusted 
Communications Networks Act of 2019 (47 U.S.C. 1601; 
commonly referred to as the ``FCC Covered List'').
(L) Any foreign entity included on the Department 
of Commerce Unverified List.
(M) The Uyghur Forced Labor Prevention Act Entity 
List maintained by the Forced Labor Enforcement Task 
Force pursuant to section 2(d)(2)(B) of the Uyghur 
Forced Labor Prevention Act (Public Law 117-78).
(N) The list of biotechnology company of concern 
pursuant to section 851 of the National Defense 
Authorization Act for Fiscal Year 2026 (Public Law 119-
60).
(O) Any other entity list designated by the 
President, the Secretary of Commerce, the Secretary of 
the Treasury, or the Secretary of Defense as 
restricting or prohibiting transactions with foreign 
entities for national security, foreign policy, or 
human rights reasons.
<all>

Plain-language analysis

Not yet analyzed.

A plain-language breakdown — including any hidden or off-intent provisions and whether the bill was fast-tracked — is generated separately and reviewed before publishing. It will appear here once ready. Until then, the verbatim text above and the official source are the record.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →